Subscribe To
LOGC / LogicBio Therapeutics (LOGC): Why The Price Substantially Fell Today
LOGC News
By Benzinga
May 9, 2022
LogicBio Therapeutics Shares Skyrocket As FDA Lifts Clinical Hold On Its Pediatric Trial
The FDA has lifted the clinical hold on LogicBio Therapeutics Inc's (NASDAQ: LOGC) LB-001 Investigational New Drug Application (IND) to resume pat more_horizontal
By PRNewsWire
March 23, 2022
LogicBio Therapeutics to Present at H.C. Wainwright Gene Therapy and Gene Editing Conference
LEXINGTON, Mass. , March 23, 2022 /PRNewswire/ -- LogicBio ® Therapeutics, Inc. (Nasdaq: LOGC), a clinical-stage genetic medicine company, today a more_horizontal
By Benzinga
February 2, 2022
Why Did LogicBio Therapeutics Shares Plunge To 52-Week Low Today?
The FDA has placed a clinical hold on LogicBio Therapeutics Inc's (NASDAQ: LOGC) Phase 1/2 SUNRISE trial of LB-001 in pediatric patients with meth more_horizontal
By Benzinga
February 2, 2022
Why Did LogicBio Therapeutics Shares Plunge To 52-Week Low Today?
The FDA has placed a clinical hold on LogicBio Therapeutics Inc's (NASDAQ: LOGC) Phase 1/2 SUNRISE trial of LB-001 in pediatric patients with meth more_horizontal
By Benzinga
February 2, 2022
Why Did LogicBio Therapeutics Shares Plunge To 52-Week Low Today?
The FDA has placed a clinical hold on LogicBio Therapeutics Inc's (NASDAQ: LOGC) Phase 1/2 SUNRISE trial of LB-001 in pediatric patients with meth more_horizontal
By Pulse2
February 2, 2022
LogicBio Therapeutics (LOGC): Why The Price Substantially Fell Today
The stock price LogicBio Therapeutics Inc (NASDAQ: LOGC) fell by over 50% during intraday trading today. This is why it happened. more_horizontal
By Pulse2
February 2, 2022
LogicBio Therapeutics (LOGC): Why The Price Substantially Fell Today
The stock price LogicBio Therapeutics Inc (NASDAQ: LOGC) fell by over 50% during intraday trading today. This is why it happened. more_horizontal
By Pulse2
February 2, 2022
LogicBio Therapeutics (LOGC): Why The Price Substantially Fell Today
The stock price LogicBio Therapeutics Inc (NASDAQ: LOGC) fell by over 50% during intraday trading today. This is why it happened. more_horizontal
